- and -Opioid Receptor Antagonists Reduce Levodopa-Induced Dyskinesia in the MPTP-Lesioned Primate Model of Parkinson's Disease

By Henry B.   Fox S.H.   Crossman A.R.   Brotchie J.M.  

Experimental Neurology, Vol. 171, Iss. 1, 2001-09 ,pp. : 139-146

Elsevier

Access to resources Recommend Favorite

Antiparkinsonian Actions of Ifenprodil in the MPTP-Lesioned Marmoset Model of Parkinson's Disease

By Nash J.E.   Fox S.H.   Henry B.   Hill M.P.   Peggs D.   McGuire S.   Maneuf Y.   Hille C.   Brotchie J.M.   Crossman A.R.  

Experimental Neurology, Vol. 165, Iss. 1, 2000-09 ,pp. : 136-142

Elsevier

Access to resources Recommend Favorite

Ropinirole versus l-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia

By Ravenscroft P.   Chalon S.   Brotchie J.M.   Crossman A.R.  

Experimental Neurology, Vol. 185, Iss. 1, 2004-01 ,pp. : 36-46

Elsevier

Access to resources Recommend Favorite

Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease

By Henry B.   Duty S.   Fox S.H.   Crossman A.R.   Brotchie J.M.  

Experimental Neurology, Vol. 183, Iss. 2, 2003-10 ,pp. : 458-468

Elsevier

Access to resources Recommend Favorite

Striatal Cannabinoid CB1 Receptor mRNA Expression Is Decreased in the Reserpine-Treated Rat Model of Parkinson's Disease

By Silverdale M.A.   McGuire S.   McInnes A.   Crossman A.R.   Brotchie J.M.  

Experimental Neurology, Vol. 169, Iss. 2, 2001-06 ,pp. : 400-406

Elsevier

Access to resources Recommend Favorite